Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review

Abstract

BACKGROUND The usefulness of residual tumor resection after epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment remains unclear. We describe two patients who underwent residual tumor resection after responding to EGFR-TKIs for advanced non-small cell lung cancer (NSCLC) harboring EGFR gene mutations, along with a review of the… (More)
DOI: 10.1186/s13019-017-0668-3

Topics

3 Figures and Tables

Cite this paper

@inproceedings{Yamamoto2017SurgicalRO, title={Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review}, author={Yoko Yamamoto and Ken Kodama and Tomohiro Maniwa and Masashi Takeda}, booktitle={Journal of cardiothoracic surgery}, year={2017} }